Home > About Nobivac > History of innovation

Strong bonds then. Even stronger bonds now.

Merck Animal Health continually brings you breakthrough solutions to meet your needs.

Year Innovation
1995 Parvovirus: a revolution in canine vaccination. The first high titer, low passage vaccine against Canine Parvovirus (CPV) and the first to break through levels of maternally derived antibodies to allow puppies to complete their primary course vaccinations at 12 weeks of age.
1996 Nobivac Parvo 2b: relevant protection where you need it. The first parvo 2b strain incorporated in a vaccine.
1998 Feline Bordetella: Nobivac is the first to develop a feline Bordetella vaccine.
1999 Feline HCP vaccine: first feline vaccine shown to cross-protect against CPV.
2003 Advanced Delivery Technology (ADT): Nobivac introduces ADT for intra-nasal canine cough to avoid accidental injections.
2005 Canine DAP vaccine: First to offer USDA-approved 3-year duration of immunity (DOI).
2006 Feline HCP vaccine: First to offer USDA-approved 3-year duration of immunity (DOI).
2008 Nobivac Parvo - cross-protection against CPV type 2c: the first parvovirus vaccine with published evidence of complete protection against the newly-emerged CPV type 2c.
2009 Canine Influenza Virus (CIV): First to develop vaccine against the newly emerged H3N8.
2009 Nobivac Lyme: the first Lyme disease vaccine specifically designed to trigger borreliacidal antibodies against two Borrelia burgdorferi antigens, OspA and OspC.
2010 Nobivac FeLV 2 year DOI: the first FeLV vaccine that provides a 2 year duration of immunity.
2011 Nobivac Lepto 4: the first 4-way leptospirosis vaccine indicated to aid in the prevention of disease, mortality and urinary shedding caused by all 4 major serovars.
2015 Canine Influenza Vaccine H3N2: aids in the control of disease caused by canine influenza virus H3N2. This vaccine is conditionally licensed and has reasonable expectation of efficacy and safety.
2016 Nobivac Canine Flu Bivalent: the convenient canine influenza vaccine that aids in the control of disease caused by canine influenza virus H3N8 and H3N2
2016 Nobivac® Intra-Trac® Oral Bb: the convenient vaccine against bordetella only.
Nobivac

Canine Cough, or Canine Infectious Respiratory Disease Complex (CIRDC), is a highly contagious respiratory disease in dogs. Found worldwide, the disease will affect a relatively high percentage of dogs in their lifetime. Learn how you can do your part to protect against Canine Cough and keep bonds strong.

READ MORE
  • Rabies causes over 55,000 deaths in people each year in Africa and India. Learn how you can help eliminate this deadly disease by protecting your pet with Nobivac vaccines.

    JOIN THE FIGHT
  • Create stronger bonds by educating yourself on the importance of vaccinating your pets. Keep informed about the benefits of vaccination with our helpful animation.

    WATCH THE VIDEO
  • Learn More about Leptospirosis and vaccines that can help prevent it.

    VISIT STOPLEPTO.COM